C. Werner, H. Hopf, J. Grunenberg, P. G. Jones
2. 5,6,7,8,11,12,13,14-Octaphenyl-9,10-dihydrotribenzo[a,c,e]cyclo- methane, and the combined organic phases were passed through a
FULL PAPER
octene (6): A solution of 1 (50 mg, 0.32 mmol) and 4 (384 mg,
1 mmol) in toluene (50 mL) was heated under reflux for 2 d. The
solvent was removed in vacuo and the remaining product mixture
purified by column chromatography (silica gel; cyclohexane/dichlo-
romethane = 1:1): 259 mg of 6 (91%), colorless prisms (dichloro-
methane), m.p. 160–170 °C. 1H NMR (400 MHz, CDCl3): δ =
pad of silica gel. After solvent removal and silica gel chromatog-
raphy (cyclohexane) 138 mg (91%) of 24 was obtained as a color-
less, glassy solid; m.p. 81 °C. 1H NMR (400 MHz, CDCl3): δ =
3.32–3.39 (m, 4 H, CH2CH2), 7.37–7.47 (m, 3 H, 6-, 5-, 16-H), 7.51
(s, 1 H, 8-H), 7.52–7.55 (m, 4 H, Ar-H), 7.88 (d, Jo = 6.1 Hz, 1 H,
7-H), 7.99 (d, Jo = 7.4 Hz, 1 H, 4-H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 28.48 (t, C-1), 29.04 (t, C-2), 120.12 (d, C-8), 124.43
(d, C-4), 124.70 (d, C-7), 125.45 (d, C-6), 127.14 (d, C-16), 128.33
3
2.50–2.55 (m, 2 H, CH2), 2.72–2.80 (m, 2 H, CH2), 6.04 (d, Jo =
7.7 Hz, 2 H, Ar-H), 6.56–7.14 (m, 44 H, Ar-H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 26.90 (t, CH2), 32.12 (t, CH2), 124.87 (d), (d, C-5), 128.37 (d, C-15), 129.96 (d, C-14), 131.59 (s, C-12), 132.42
124.91 (d), 125.19 (d), 125.69 (d), 125.78 (d), 126.16 (d), 126.37 (d),
126.41 (d), 126.63 (d), 126.97 (d), 127.14 (d), 130.91 (d), 131.06 (d),
131.16 (d), 131.34 (d), 131.60 (d), 131.70 (d), 132.10 (d), 132.36 (d),
136.87 (s), 139.18 (s), 139.27 (s), 140.10 (s), 140.13 (s), 140. 35 (s),
140.45 (s), 140.77 (s), 141.00 (s), 141.30 (s, Ar-C) ppm. IR (KBr):
(s, C-9), 134.69 (s, C-10), 136.94 (s, C-13), 142.75 (s, C-3), 143.92
(s, C-11) ppm. IR (KBr): ν = 3052 (w), 2971 (m), 2932 (s), 1509
˜
(m), 1403 (m), 871 (s), 757 (s), 747 (s), 697 (s) cm–1. UV/Vis (aceto-
nitrile): λmax (logε) = 192 (4.66), 228 (4.75), 294 nm (4.01). MS
(70 eV): m/z (%) = 230 (97) [M+], 215 (100), 202 (28). C18H14
(230.31): calcd. C 93.87, H 6.13; found C 93.73, H 6.07.
ν = 3055 (s), 2925 (s), 1442 (s), 1028 (s), 738 (s), 699 (s) cm–1.
˜
UV/Vis (acetonitrile): λmax (logε) = 194 (5.23), 240 nm (4.86). MS
(70 eV): m/z (%) = 866 (27), 865 (75), 864 (100) [M+], 787 (4), 695
(4), 432 (10), 382 (12). HRMS: calcd. 864.3756; found 864.375. X-
ray: see main section and below.
6. 3-Chloro-1,2-dihydrocyclopenta[a]indene (23): As described under
5 a solution of 1 (100 mg, 0.66 mmol) was prepared, but in dichlo-
romethane (100 mL). Work-up as described above furnished 14
(118 mg, 95%) as a colorless, glassy solid; m.p. 52 °C. 1H NMR
(400 MHz, CDCl3): δ = 3.31–3.33 (m, 2 H, CH2), 3.36–3.38 (m, 2
H, CH2), 7.41 (s, 1 H, 8-H), 7.47 (m, Jo = 7.9, Jm = 1.5 Hz, 1 H,
3. 1,2;5,6-Bis(dicobalthexacarbonyl)-3,4-benzocyclooctene (7): To a
solution of 1 (100 mg, 0.658 mmol) in anhydrous diethyl ether
(50 mL) was added under nitrogen Co2(CO)8 (674 mg, 1.97 mmol).
The mixture was stirred for 20 min at room temp. (gas formation),
and the solvent was removed by rotary evaporation. After 4 h un-
der vacuum the adduct was dissolved under nitrogen in dichloro-
methane, the solution was filtered through a pad of silica gel, and
the solvent was removed in vacuo. The remaining black residue was
recrystallized from dichloromethane/methanol: 310 mg (65%) of
dark brown/black needles, decomp. temp. Ͼ300 °C. 1H NMR
(400 MHz, CDCl3): δ = 3.48 (s, 4 H, CH2CH2), 7.31–7.33 (m, 2 H,
Ar-H), 7.59–7.61 pm (m, 2 H, Ar-H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 38.44 (t, CH2CH2), 89.90 (s, C-2), 96.24 (s, C-1),
128.88 (d, Ar-C), 134.57 (d, Ar-C), 136.15 (s, Ar-C), 199.37 (s, CO)
6-H), 7.54 (m, Jo = 8.3, Jm = 1.5 Hz, 1 H, 5-H), 7.82 (d, Jo
=
7.9 Hz, 1 H, 7-H), 8.24 (d, Jo = 8.3 Hz, 1 H, 4-H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 28.23 (t, C-1), 28.36 (t, C-2), 119.72 (d, C-
4), 123.14 (s, C-9), 123.56 (d, C-7), 125.25 (d, C-8), 125.51 (d, C-
6), 128.21 (d, C-5), 130.62 (s, C-12), 135.28 (s, C-10), 141.56 (s, C-
3), 144.09 (s, C-11) ppm. IR (KBr): ν = 2970 (m), 2929 (s), 1417
˜
(m), 1249 (s), 938 (s), 871 (s), 849 (s), 756 (s) cm–1. UV/Vis (acetoni-
trile): λmax (logε) = 228 (4.89), 274 (3.79), 284 (3.87), 294 nm (3.75).
MS (70 eV): m/z (%) = 190 (33) [M+, 37Cl], 188 (100) [M+, 35Cl],
154 (10), 153 (83), 152 (68), 151 (22), 150 (12), 76 (25). HRMS:
C12H9Cl: calcd. 188.0392; found 188.039.
7. Oxmercuration/Hydration of 1. 3-Methoxy-1,2-dihydrocyclo-
penta[a]indene (28) and (3-Methoxy-1,2-dihydrocyclopenta[a]inden-
8-yl)mercury Chloride (27): A mixture of HgO (40 mg), tri-
chloroacetic acid (10 mg) and BF3·Et2O (0.1 mL) was heated at
60 °C for several min and then added to a solution of 1 (100 mg,
0.66 mmol) in methanol (50 mL) under nitrogen. The mixture was
stirred for 1 h at 20 °C, and water (200 mL) was added. After thor-
ough extraction with diethyl ether the combined organic phases
were passed through a pad of silica gel, dried (sodium sulfate), and
the solvent was removed by rotary evaporation. The residue thus
obtained was separated by silica gel column chromatography (cy-
clohexane/dichloromethane = 1:1). First fraction: 30.3 mg (25%)
ppm. IR (KBr): ν = 3043 (w), 2934 (w), 2082 (vs), 2007 (vs), 1431
˜
(w), 514 (s), 494 (s) cm–1. UV/Vis (acetonitrile): λmax (logε) = 200
(4.51), 222 (4.47), 232 nm (4.53). MS (70 eV): m/z (%) = 724 (12)
[M+], 696 (3), 668 (96), 640 (31), 612 (17), 584 (79), 556 (100),
528 (72), 500 (55), 472 (51), 444 (42), 416 (19), 388 (79), 329 (33).
C24H8Co4O12 (724.06): calcd. C 39.81, H 1.11; found C 38.81, H
0.99.
4. 1,2-Benzo-1,3,7-cyclooctatriene (9): To a solution of 1 (30 mg,
0.2 mmol) in anhydrous diethyl ether (50 mL) was added under ni-
trogen LiAlH4 (38 mg, 1 mmol), and the mixture was stirred for
1 h at room temperature. For work-up water (50 mL) was added,
and the product mixture was extracted carefully with diethyl ether
(4ϫ50 mL). After drying (sodium sulfate) the solvent was removed
by rotary evaporation and the residue purified by column
chromatography (silica gel, cyclohexane) to provide 29 mg (93%)
1
of 28, colorless needles, m.p. 56 °C. H NMR (400 MHz, CDCl3):
δ = 3.32–3.35 (m, 2 H, CH2), 3.58–3.61 (m, 2 H, CH2), 4.13 (s, 3
H, CH3O), 7.10 (s, 1 H, 8-H), 7.35–7.42 (m, 2 H, 5-, 6-H), 7.73 (d,
Jo = 7.4 Hz, 1 H, 7-H), 8.16 (d, Jo = 7.5 Hz, 1 H, 4-H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 29.69 (t, CH2), 29.93 (t, CH2), 57.11
(q, CH3O), 113.32 (d, C-4), 121.56 (s, C-9), 122.03 (d, C-7), 123.74
(d, C-8), 125.06 (s, C-12), 125.18 (d, C-5), 127.32 (d, C-6), 135.22
1
of 9 as a colorless oil. H NMR (400 MHz, CDCl3): δ = 2.30–2.34
(m, 4 H, CH2CH2), 5.90–5.98 (m, 2 H, 4-H), 6.55 (d, 3J = 11.8 Hz,
2 H, 3-H), 7.10–7.14 (m, 2 H, Ar-H), 7.18–7.25 (m, 2 H, Ar-H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 27.03 (t, CH2CH2), 126.49
(d, C-9, –12), 129.57 (d, C-10, –11), 129.87 (d, C-2, –5), 132.57 (d,
C-1, –6), 135.92 (s, C-3, –4) ppm. MS (70 eV): m/z (%) = 156 (22)
[M+], 141 (21), 128 (100), 115 (38). The spectroscopic and analyti-
cal data agree with those reported in the literature.[9].
(s, C-10), 145.30 (s, C-11), 147.80 (s, C-3) ppm. IR (KBr): ν = 3005
˜
(w), 2923 (s), 2854 (m), 1591 (s), 1364 (s), 1330 (s), 1279 (s), 1110
(s), 835 (s), 739 (s) cm–1. UV/Vis (acetonitrile): λmax (logε) = 232
(4.57), 294 nm (3.61). MS (70 eV): m/z (%) = 184 (100) [M+], 169
(99), 153 (22), 141 (86), 115 (53). HRMS: C13H12O: calcd:
184.0888; found 184.088. Second fraction: 30.3 mg (11%) of 27,
colorless needles, m.p. 235 °C. 1H NMR (400 MHz, CDCl3): δ =
3.30–3.33 (m, 2 H, CH2), 3.51–3.89 (m, 2 H, CH2), 4.12 (s, 3 H,
CH3O), 7.40 (m, 1 H, 6-H), 7.46 (m, 1 H, 5-H), 7.71 (d, Jo = 7.8 Hz,
1 H, 7-H), 8.21 (m, 1 H, 4-H) ppm. 13C NMR (100 MHz, CDCl3):
δ = 29.02 (t, CH2), 31.08 (t, CH2), 57.24 (q, CH3O), 121.41 (s, C-
5. 3-Phenyl-1,2-dihydrocyclopenta[a]indene (24): To a solution of 1
(100 mg, 0.66 mmol) in anhydrous benzene (100 mL) was added
under nitrogen BF3·Et2O (0.2 mL) and the mixture kept at room
temperature for 30 min. The mixture was hydrolyzed with hydrogen
carbonate solution (100 mL), extracted carefully with dichloro-
4032
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 4027–4034